hospitalization were evaluated. Frequency of use of individual antibiotic agents was determined. The Cochran-Armitage test was used to assess trends RESULTS: 5,657,523 women admitted for delivery hospitalization were included. 1,899,374 (33.5%) delivered via cesarean and 3, 758,149 (66.4%) via vaginal delivery. 3,235,106 (57.2%) of women received antibiotics including 1,547,060 during vaginal (41.1%) and 1,688,046 (88.9%) during cesarean hospital. Cephalosporins were the most common antibiotic administered (50.1% of all hospitalizations) followed by penicillins (36.2%) and macrolides (36.2%) (Table) . The use of antibiotics during cesarean increased from 87.3% in 2006 to 89.5% in 2015 (P<0.01) while the use of antibiotics decreased for vaginal deliveries from 47.7% to 34.0% (p<0.01) (Figure 1 ). The proportion of women undergoing vaginal delivery receiving antibiotics in the setting of specific indications increased with GBS positive women accounted for 43.0% of women in 2015 versus 30.8% in 2006. Similarly, the proportion of women undergoing vaginal delivery receiving antibiotics for PPROM (4.9% to 7.9%), chorioamnionitis (2.0% to 4.5%), and endometritis (0.2% to 0.4%) also increased significantly from 2006 to 2015(p<0.01). CONCLUSION: These findings support clinical uptake of evidencebased recommendations. In addition to a large majority of women undergoing cesarean receiving antibiotics, antibiotic use decreased among women undergoing vaginal delivery overall while the proportion of antibiotic receipt associated with specific indications increased.
335 Does race affect late preterm neonatal respiratory morbidity?
Maria Andrikopoulou, Eve E. Overton, Sierra J. Seaman, Conrad N. Stern-Ascher, Cynthia Gyamfi-Bannerman Columbia University Irving Medical Center, New York, NY OBJECTIVE: Differences in respiratory disease by race are well described in early preterm infants, but largely unknown for late preterm infants. Our objective was to determine whether neonatal respiratory morbidity differs by race in neonates born late preterm. STUDY DESIGN: Secondary analysis of a randomized trial of women at high risk for late preterm delivery. Our study was limited to women with non-anomalous, singleton gestations delivering between 34+0 to 36+6 weeks. Women were categorized into 4 groups by race: Black, White, Asian, or other/mixed. Primary outcome was a neonatal composite of treatment in the first 72 hours (CPAP or high flow nasal cannula >2 hours, oxygen >4 hours, ECMO or mechanical ventilation) or stillbirth or neonatal death before 72 hours. Secondary outcomes include major respiratory morbidity (MRM, the primary outcome, extending CPAP or high-flow nasal cannula to >12 continuous hours and oxygen to at least 24 continuous hours) and other outcomes listed in Table 1 . The primary and secondary outcomes were assessed in the active and placebo groups separately, and the full cohort was assessed for treatment interaction with race. We fit a logistic regression model to adjust for confounders related to respiratory morbidity. RESULTS: Of 2,331 included women, 26.9% (n¼ 627) were Black/ African American, 57.1% White (n¼1333), 3.56% Asian (n¼83) and 12.36% (n¼288) were other/mixed. In the placebo group the rate of the primary outcome was significantly higher in Whites (18.6%) and Asians (22.8%) compared to the African American/Black group (12.3%) (p 0.03) (table 1). Adjusting for confounders, Black infants still had lower but non-significant rates of the primary outcome. The primary predictor for respiratory morbidity was a prior pregnancy with neonatal respiratory morbidity. Findings were similar in the steroid group (Table 1) , but MRM was less common in black compared with white infants (aOR 0.45, 95%CI 0.24, 0.83) (table 2) . However, a prior pregnancy with neonatal respiratory complications was no longer associated with respiratory morbidity after receipt of betamethasone. Assessing the full cohort, there were no significant interactions between steroids and race. CONCLUSION: Late term respiratory morbidity is lower in black infants and reduced further by steroid administration. While history of pregnancy with previous neonatal respiratory disease is the strongest risk factor for recurrence, this risk factor was mitigated by receipt of steroids.
336 An antenatal lifestyle intervention in overweight and obese pregnancy improves sleep behaviour and maternal wellbeing 
OBJECTIVE:
The national sleep foundation recommends 7-9 hours of sleep per night for adults. Pregnancy is associated with an overall reduction in sleep duration and general wellbeing. Restrictive sleep is associated with metabolic disturbance in the non-pregnant population and adverse pregnancy outcomes. We sought to investigate the effect of the PEARS intervention on sleep duration and behaviours and general wellbeing. We also sought to examine the association between suboptimal sleep (<7 hours) and maternal and fetal metabolic and pregnancy outcomes on the entire patient cohort STUDY DESIGN: Secondary analysis of the PEARs study cohort-a RCT of the effects of a complex behavioral antenatal lifestyle intervention with smartphone app support on the incidence of GDM in overweight and obese pregnancies. 474 women with sleep and wellbeing data at both study entry (circa 16 weeks) and in the 3 rd trimester (28-34 weeks' gestation) were included in the analysis. At baseline, 28 weeks and birth, blood samples were taken for analysis of glucose, insulin, c-peptide, HOMA, and lipids. Data pertaining to pregnancy outcomes was also recorded. RESULTS: Mean sleep duration and wellbeing was significantly higher in the intervention group compared to control 400.4 AE 81 vs. 383.3 AE 71 minutes p¼ 0.04 and 62.7 AE 15.3 vs. 59.3 AE 14.1 p¼ 0.03. The intervention group was significantly more likely to achieve 'optimum sleep time' , p¼0.04. Insulin resistance (HOMA 2 IR) in early pregnancy was greater in those that had severe sleep restriction < 6 hours of sleep per night . p¼0.03. Moderate and severe sleep restriction in the 3rd trimester was associated with higher lipid profiles, less adherence to GWG guidelines and lower breastfeeding rates (Table  1&2) CONCLUSION: An antenatal healthy lifestyle intervention improves sleep behaviour in an at-risk population which is imperative to achieve optimum maternal weight gain, metabolic health and breastfeeding rates in pregnancy
